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ABSTRACT
Psoriasis is a chronic, systemic, and immune-mediated skin disease that can affect physical,
psychological and social functions of patients leading to a significant impact on sexual
dysfunction. The aim of study was to evaluate the relationship between disease severity and
degree of stress with sexual dysfunction in psoriasis patients. This was an observational study
using case control design. Subjects were psoriasis vulgaris patients who visited Squamous
Division, Polyclinic of Department of Dermato-Venereology, Dr. Sardjito General Hospital/Faculty
of Medicine Universitas Gadjah Mada, Yogyakarta. Disease severity was assessed using psoriasis
area severity index (PASI), whereas sexual dysfunction was evaluated using arizona sexual
experience scale (ASEX) and Psoriasis-related psychological stress was assessed using psoriasis
life stress inventory (PLSI). Among 93 patients of psoriasis, 38 patients (40.8%) suffered from
sexual dysfunction. Factors that influence the occurrence of sexual dysfunction in psoriasis
patients were disease severity (p=0.00), psoriasis-related stress (p=0.00), disease onset (p=0.03),
age (p=0.04) and joint pain (p=0.04). In conclusion, disease severity and degree of stress are
associated with sexual dysfunction on psoriasis patients.
ABSTRAK
Psoriasis merupakan penyakit kronis, sistemik, dan kelainan sistem imun kulit yang dapat
mempengaruhi fungsi fisik, psikologi dan sosial penderita sehingga menyebabkan gangguan
fungsi seksual yang signifikan. Penelitian ini merupakan penelitian observasional menggunakan
rangcangan kasus kontrol. Subjek penelitian adalah penderita psoriasis vulgaris yang berkunjung
ke Divisi Skuamosa, Poliklinik Bagian Kulit dan Kelamin, Rumah Sakit Umum Pusat Dr. Sardjito/
Fakultas Kedokteran, Universitas Gadjah Mada, Yogyakarta. Keparahan penyakit ditetapkan
menggunakan psoriasis area severity index (PASI), sedangkan gangguan seksual dievaluasi
menggunakan arizona sexual experience scale (ASEX) dan tingkat stres terkait psoriasis ditetapkan
menggunakan psoriasis life stress inventory (PLSI). Diantaran 93 penderita psoriasis, 38 penderita
(40,8%) mengalami gangguan fungsi seksual. Faktor yang mempengaruhi kejadian gangguan
fungsi seksual adalah keparahan penyakit (p=0,00), stres terkait psoriasis (p=0,00), munculnya
penyakit (p=0,03), umur (p=0,04) dan nyeri sendi (p=0,04). Dari penelitian ini dapat disimpulkan,
keparahan penyakit dan derajat stres berkaitan dengan gangguan seksual pada penderita psoriasis.
Keywords: psoriasis - sexual dysfunction - psoriasis area severity index - arizona sexual experience
scale - psoriasis life stress inventory
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INTRODUCTION
Psoriasis is a chronic, systemic, immune-
mediated skin disease characterized by
erythematous, scaly plaques that can itch and
bleed.1,2 The prevalence of psoriasis varies from
country to country and by ethnic groups. It is
estimated that the prevalence of psoriasis ranges
from 0.5% to 4.6% worldwide. The reason for
the geographic variation in prevalenve is still
unknown.3 The prevalence of psoriasis in
Caucasian population is etimated to be 2-3%.
In the United State, 2.1% among adult
population are found to have psoriasis.4 In the
United Kingdom, 1.5% among 7.5 million
patients who were registered with a general
practitioner have psoriasis.5
The cause of psoriasis is not fully known.
However, the evolving evidence suggests that
psoriasis is a complex disorder caused by the
interaction of multiple genes, the immune system,
and environmental factors.6,7Recent studies have
demonstrated that psoriasis has a significant
negative impact on patients’ quality of life as
other chronic diseases such as cancer, arthritis,
hypertension, heart disease, diabetes and
depression.2,8-10 Additional studies have also
demonstrated that psoriasis has both social and
psychological impacts on patients.11-13
One of the aspects related to quality of life
that is affected by psoriasis is the sexual
dysfunction. Psoriasis is commonly associated
with low self-esteem, dissatisfaction with
relationships, depression, and suicidal thoughts
leading to the decrease of sexual activities and
desire.14-17 It was reported that 38-50% patients
with psoriasis have sexual problems.11,12,15
However, this sexual problems is not often
considered by clinicians. This study was
conducted to evaluate the correlation between
the disease or illness severity and degree of
stress due to psoriasis with sexual dysfunction
among the outpatients of Department of
Dermato-Venereology, Dr. Sardjito General




This was an observational study using case
control design. Subjects were recruited from
psoriasis vulgaris patients visiting Squamous
Division, Polyclinic of Department of Dermato-
Venereology, Dr. Sardjito General Hospital,
Yogyakarta and fulfilled the inclusion and
exclusion criteria. The inclusion creteria were
patients with plaque type psoriasis, aged 18-
55 years old, good marriage status, sexually
active, understood well Indonesian language and
agreed to join the study by signing an informed
consent. The exclusion criteria were patients
with history of antidepressants consumption and
suffering other chronic diseases. Protocol of the
study has been approved by the Health Research
Ethics Committee of the Faculty of Medicine,
Universitas Gadjah Mada, Yogyakarta.
Disease severity measurements
Detailed dermatological examination and
documentation of disease severity was
conducted by a dermatologist using psoriasis
area severity index (PASI).17 PASI combined
the assessment of the severity of lesions and
the area of the body affected. The lesions of the
skin were divided into erythema, infiltration
and desquamation on a scale from 0 (none) to 4
(maximum). The area body affected included
head, arms, trunk and legs on a percentage of
affected area. PASI combined these two
assessment into single score in the range 0 (no
disease) to 72 (maximal disease).
Sexual dysfunction measurement
The presence or absence of sexual
dysfunction was assessed using arizona sexual
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experience scale (ASEX) developed by
M cGahuey et al.18 This assessment was a self-
report questionnaire administered by a clinician
consisting of 5 items rated on a 6-point scale.
Each item explored a particular aspect of
sexuality namely 1) sexual drive, 2) arousal, 3)
penile erection/vaginal lubrication, 4) ability
to reach orgasm and 5) satisfaction from orgasm.
Patient was considered to have sexual
dysfunction if the total score was > 18 or a single
i tem had score5 or three items had score4.
Psoriasis-related psychological stress
measurement
Psoriasis-related psychological stress was
assessed using psoriasis life stress inventory
(PLSI) developed by Gupta and Gupta.19 The
PLSI used was a 15-item questionnaire rated
on a 4-point scale providing a total score in the
range from 0 to 45. Patient was considered to
have high stress associated to psoriais if the
total score was10 and patient was considered
to have low stress associated to psoriasie if the
total score was <10.
Statistical analysis
Univariate analysis was conducted to
evaluate variations in the frequency distribution
of subjects. Bivariate analysis using Chi-square
and Spearman’s was conducted to evaluate the
relationship between the independent variables
with one dependent variable.
RESULTS
A total of 93 patients with psoriasis vulgaris
were enrolled in this study. The characteristic
of patients is presented in TABLE 1. Mean of
patients age was 37.85 ± 7.90 years ranging
from 20 to 54 years. The majority of patients’
education (46.2%) were Senior High School.
Range of PASI score, duration of illness and
age at onset of illness were 0.8-28.8, 1-20
years, and 19-45 years old, respectively.
Among 93 patients with psoriasis vulgaris
enrolled in this study, 38 patients (40.8%)
suffered from sexual dysfunction. The
relationship between sex, genital lesion and
joint pain with the occurrence of sexual
dysfunction is presented in TABLE 2. Sex and
genital lesion were not associated with sexual
dysfunction (p=0.610 and p=0.169), whereas
joint pain was associated with the occurrence
of sexual dysfunction (p=0.043). Patients with
joint pain experienced more sexual dysfunction.
The relationship between age, onset,
duration of illness, PASI and PLSI score with
the occurrence of sexual dysfunction is
presented in TABLE 3. Duration of illness was
not associated with the occurrence of sexual
dysfunction (p=0.10). However, age (p=0.04)
and onset of illness (p=0.03) were associated
with the occurrence of sexual dysfuntion.
Psoriasis patients with early onset and younger
age had higher risk of sexual dysfunction.
Furthermore, the relationship of PASI and PLSI
scores with the occurrence of sexual dysfunction
was also observed (p=0.00). Sexual dysfunction
was more observed in patients with higher
stress and higher illness severity.
TABLE 1. Characteristics of subjects. Data are
presented as mean±SD, frequency
(percent) or range
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TABLE 2. Relationship between sex, genital lession and joint pain with the
occurrence of sexual dysfunction
TABLE 3. Relationship between age, onset, duration of
illness, PASI and PLSI scores with the occurrence
of sexual dysfunction. Data are presented as mean
± SD
No relationship between age (p=0.24) and
disease onset (p=0.22) with disease severity
(PASI score) was observed in this study
(TABLE 4).
TABLE 4. Relationship between age and
onset of disease with PASI score
DISCUSSION
Many studies have demonstrated that
psoriasis has a significant negative impact on
the patient’s quality of life such as sexual
dysfunction.14-17 This study found that 40.8% of
psoriasis patients had sexual dysfunction. The
occurrence of sexual dysfunction on psoriasis
patients has been reported by some authors with
similar results. In United States, the occurrence
of sexual dysfunction among psoriasis patients
was 40.8%15 while other study conducted by
Young12 reported that 38.0% of psoriasis
patients had sexual dysfunction. Ginsburg and
Link20 also found that 30-70% psoriasis patients
had sexual dysfunction.
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Joint pain was associated with the
occurrence of sexual dysfunction in this study.
There are more patients with joint pain who
experienced sexual dysfunction compared to
patients with no joint pain. Similar result had
been reported by Gupta and Gupta15 that showed
that joint pain caused sexual dysfunction on
psoriasis patients. Joint pain is the main
noncutaneus condition related with psoriasis.21
It may cause difficulties in doing sexual activity
on psoriasis patients.
This study also found that age, onset of ilness,
illness severity and stress were associated with
the occurence of sexual dysfunction. Psoriasis
patients with early onset and younger age had
higher risk of sexual dysfunction. Moreover,
sexual dysfunction on psoriasis patients were
more observed in patients with higher stress and
higher illness severity.
Henseler and Christhopers23 and Sampogna
et al.24 reported that the higher illness severity
occured in the younger age of psoriasis patients.
It may cause higher occurence of sexual
dysfunction in younger patients than older
patients. It was found in this study that the
younger patients had the higher disease severity
(PASI score of 17.4) compared to the older
patients (PASI score of 10.7) (TABLE 4).
However, the difference was not significant. The
association between the disease severity (PASI)
and the occurrence of sexual dysfunction on
psoriasis patients is still a controversy. Ramsay
and O’reagen14 and Sompogna et al.19 are some
who agreed and reported that the disease
severity is associated with sexual dysfunction
in psoriasis patients. In contrast, Fortune et al.24
found that the association between the disease
severity with sexual dysfunction was not
observed. The sexual dysfunction on psoriasis
patients may be caused by patients’ depression
or stress.25 The occurrence of depression or high
stress on psoriasis patients has been reported,
as the PLSI showed a significant correlation
between clinical extent of psoriasis and other
measures of psychological distress.13,26
CONCLUSION
In conclusion, sexual dysfunction occurs in
40.8% psoriasis patients who visited Squamous
Division, Polyclinic of Department of Dermato-
Venereology, Dr. Sardjito General Hospital,
Yogyakarta. The sexual dysfunction is
associated with age, onset of ilness, illness
severity and degree of stress on psoriasis
patients.
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